People's United Financial’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$1.23M Sell
1,757
-1,236
-41% -$782K 0.03% 301
2021
Q4
$1.89M Buy
2,993
+2,503
+511% +$1.54M 0.05% 241
2021
Q3
$297K Buy
490
+3
+0.6% +$1.86K 0.01% 614
2021
Q2
$272K Sell
487
-90
-16% -$45.6K 0.01% 635
2021
Q1
$273K Sell
577
-157
-21% -$76.4K 0.01% 609
2020
Q4
$355K Sell
734
-177
-19% -$95.5K 0.01% 532
2020
Q3
$510K Sell
911
-51
-5% -$30.9K 0.01% 426
2020
Q2
$600K Buy
962
+230
+31% +$131K 0.02% 384
2020
Q1
$357K Buy
+732
New +$302K 0.01% 441
2019
Q2
Sell
-700
Closed -$288K 786
2019
Q1
$288K Buy
700
+85
+14% +$35K 0.01% 616
2018
Q4
$230K Sell
615
-26
-4% -$9.52K 0.01% 661
2018
Q3
$259K Buy
+641
New +$244K 0.01% 637
2017
Q3
Sell
-454
Closed -$223K 830
2017
Q2
$223K Buy
454
+394
+657% +$172K 0.01% 600
2017
Q1
$23K Hold
60
﹤0.01% 804
2016
Q4
$22K Sell
60
-40
-40% -$15.2K ﹤0.01% 785
2016
Q3
$40K Hold
100
﹤0.01% 598
2016
Q2
$35K Sell
100
-25
-20% -$9.63K ﹤0.01% 604
2016
Q1
$45K Hold
125
﹤0.01% 574
2015
Q4
$68K Buy
125
+25
+25% +$13.5K ﹤0.01% 544
2015
Q3
$47K Buy
+100
New +$53.7K ﹤0.01% 572

Other funds holding REGN

People's United Financial's REGN Position: Q1 2022 in Review

People's United Financial reduced its Regeneron Pharmaceuticals (REGN) stake by 41% in Q1 2022, selling an estimated $782K and leaving 1,757 shares worth $1.23M. The position accounts for 0.03% of the portfolio, ranked #301.

People's United Financial first reported a position in REGN in Q3 2015 and has held it in 20 quarters since. The position peaked at $1.89M in Q4 2021. 1,095 funds tracked by Wall St. Rank hold REGN as of Q1 2022.

  • People's United Financial held 1,757 shares of Regeneron Pharmaceuticals worth $1.23M as of Q1 2022.
  • People's United Financial sold 1,236 Regeneron Pharmaceuticals shares in Q1 2022, an estimated $782K.
  • Regeneron Pharmaceuticals made up 0.03% of People's United Financial's portfolio in Q1 2022, its #301 holding.
  • People's United Financial first reported a position in Regeneron Pharmaceuticals in Q3 2015 and has held it in 20 quarters since.
  • People's United Financial's Regeneron Pharmaceuticals position peaked at $1.89M in Q4 2021.
  • 1,095 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2022.

Based on People's United Financial's 13F filing for Q1 2022, filed 10 May 2022.